1 |
H. Sugioka and Y. Moroi, Micelle formation of sodium cholate and solubilization into the micelle, Biochim. Biophys. Acta, 1394, 99-110 (1998).
DOI
ScienceOn
|
2 |
S. Reis, C.G. Moutinho, C. Matos, B. de Castro, P. Gameiro and J.J.F.C. Lima, Noninvasive methods to determine the critical micelle concentration of some bile acid salts, Anal. Biochem., 334, 117-126 (2004).
DOI
ScienceOn
|
3 |
U. Subuddhi and A.K. Mishra, Micellization of bile salts in aqueous medium: a fluorescence study, Colloids Surf. B: Biointerfaces, 57, 102-107 (2007).
DOI
ScienceOn
|
4 |
A. Coello, F. Meijide, E.R. Ninez and J.V. Tato, Aggregation behavior of bile salts in aqueous solutions, J. Pharm. Sci., 85, 9-15 (1996).
DOI
|
5 |
K. Matsuoka, M. Maeda and Y. Moroi, Micelle formation of sodium glyco- and taurocholates and sodium glyco- and taurodeoxycholates and solubilization of cholesterol into their micelles, Colloids Surf. B: Biointerfaces, 32, 87-95 (2003).
DOI
ScienceOn
|
6 |
K. Matsuoka, M. Suzuki, C. Honda, K. Endo and Y. Moroi, Micellization of conjugated chenodeoxy- and ursodeoxycholates and solubilization of cholesterol into their micelles: comparison with other four conjugated bile salts species, Chem. Phys. Lipids, 139, 1-10 (2006).
DOI
ScienceOn
|
7 |
P.M. van Hasselt, G.E.P.J. Janssens, T.K. Slot, M. Van der Ham, T.C. Minderhoud, M. Talelli, L.M. Akkermans, C.J.F. Rijcken and C.F. van Nostrum, The influence of bile salts on the oral bioavailability of vitamin K encapsulated in polymeric micelles, J. Contr. Rel., 133, 161-168 (2009).
DOI
ScienceOn
|
8 |
N. Yoshida, Y. Moroi, R. Humphry-Baker and M. Graetzel, Dynamics for solubilization of naphthalene and pyrene into n-decyltrimethylammonium perfluorocarboxylate micelles, J. Phys. Chem. A, 106, 3991-3997 (2002).
DOI
ScienceOn
|
9 |
S. Gould and R.C. Scott, 2-Hydroxypropyl-ß-cyclodextrin (HP-ß-CD): a toxicological review, Food Chem. Toxicol., 43, 1451-1459 (2005).
DOI
ScienceOn
|
10 |
X. Tan and S. Lindenbaum, Studies on complexation between ß-cyclodextrin and bile salts, Int. J. Pharm., 74, 127-1353 (1991).
DOI
ScienceOn
|
11 |
I.K. Chun, D.D. Kim, Y.J. Wang and Y.W. Chien, Permeation enhancement of methionine enkephalin by combinations of enzyme inhibitors and enhancers, S.T.P. Pharma Sci., 6, 148-156 (1996).
|
12 |
M.H. Davidson, P. Lukacsko, J.X. Sun, G. Phillips, E. Walters, A. Sterman, R. Niecestro and L. Friedhoff, A multiple-dose pharmacodynamic, safety and pharmacokinetic comparison of extended- and immediate-release formulations of lovastatin, Clin. Ther., 24, 112-125 (2002).
DOI
ScienceOn
|
13 |
N.Y. Lee and I.K. Chun, Enhanced dissolution of simvastatin by solid dispersion with water-soluble carriers, Dongduk Pharm. Res., 12, 1-12 (2008).
|
14 |
M.A. Hammad and B.W. Müller, Increasing drug solubility by means of bile salt-phosphatidylcholine-based mixed micelles, Eur. J. Pharm. Biopharm., 46, 361-367 (1998).
DOI
ScienceOn
|
15 |
L.A. Woollett, Y. Wang, D.D. Buckley, L. Yao, S. Chin and N. Granholm, Micellar solubilisation of cholesterol is essential for absorption in humans, Gut, 55, 197-204 (2006).
DOI
ScienceOn
|
16 |
A.F. Hofmann, Intestinal absorption of bile acids and biliary constituents: the intestinal component of the enterohepatic circulation and the integrated system. In: Physiology of the Gastrointestinal Tract (3rd ed., vol. 2), edited by Johnson L.R., Alpers, D.H., Jacobson, E.D and Walsh, J.H., New York, Raven, 1994, p. 1845-1865
|
17 |
A.W. Alberts, Discovery biochemistry and biology of lovastatin, Am. J. Cardiol., 62, J10–J15 (1998).
DOI
ScienceOn
|
18 |
A. Corsini, S. Bellosta, R. Baetta, R. Fumagalli, R. Paoletti and F. Bernini, New insights into the pharmacodynamic and pharmacokinetic properties of statins, Pharmacol. Ther., 84, 413-428 (1999).
DOI
ScienceOn
|
19 |
G.A. McClelland, R.J. Stubbs, J.A. Fix, S.A. Pogany and G.M., Zentner, Enhancement of 3-hydroxy-3-methylglutarylcoenzyme A (HMG-CoA) reductase inhibitor efficacy through administration of a controlled-porosity osmotic pump dosage form. Pharm. Res., 8, 873-876 (1991).
DOI
ScienceOn
|
20 |
R.H. Bradford, C.L. Shear, A.N. Chremos, C.A. Dujovne, F.A. Franklin, R.B. Grillo, J. Higgins, A. Langendörfer, D.T. Nash, J.L. Pool and H. Schnaper, Expanded clinical evaluation of lovastatin (EXCEL) study results: Two-year efficacy and safety follow-up, Am. J. Cardiol., 74, 667-673 (1994).
DOI
ScienceOn
|
21 |
R.W. Wang, P.H. Kari, A.Y. Lu, P.E. Thomas, F.P. Guengerich and K.P. Vyas, Biotranformation of lovastatin: IV. Identification of cytochrome P450 3A proteins as the major enzymes responsible for the oxidative metabolism of lovastatin in rat and human liver microsomes, Arch. Biochem. Biophys., 290, 355-361 (1991).
DOI
ScienceOn
|
22 |
T. Prueksartanont, R. Subramanian, X. Fang, B. Ma, Y. Qiu and J.H. Lin, Glucuronidation of statins in animals and humans: a novel mechanism of statin lactonization, Drug Metab. Dispos., 30, 505-512 (2002).
DOI
ScienceOn
|
23 |
M.V.S. Varma, S. Khandavilli, Y. Ashokraj, A. Jain, A. Dhanikula, A. Sood, N.S. Thomas, O.P. Pillai, P. Sharma, R. Gandhi, S. Agrawal, V. Nair and R. Panchagnula, Biopharmaceutic classification system: a scientific framework for pharmacokinetic optimization in drug research, Curr. Drug Metab., 5, 375-388 (2004).
DOI
ScienceOn
|
24 |
P. Sharma, M.V.S. Varma, H.P.S. Chawla and R. Panchagnula, Absorption enhancement, mechanistic and toxicity studies of medium chain fatty acids, cyclodextrins and bile salts as peroral absorption enhancers, Il Pharmaco, 60, 884-893 (2005).
|
25 |
B.K. Kang, B.Y. Yoon, K.S. Seo, S.Y. Jeung, J.H. Kil, G. Khang, H.B. Lee and S.H. Cho, Preparation of solid dosage form containing SMEDDS of simvastatin by microencapsulation. J. Kor. Pharm. Sci., 33, 121-127 (2003).
과학기술학회마을
|
26 |
S. Comini, P. Olivier, M. Riottot and D. Duhamel, Interaction of ß-cyclodextrin with bile acids and their competition with vitamins A and D3 as determined by 1HNMR spectrometry, Clin. Chem. Acta, 228, 181-194 (1994).
DOI
ScienceOn
|
27 |
F.G.J. Poelma, R. Breas and J.J. Tukker, Intestinal absorption of drugs. IV. the influence of taurocholate and L-cysteine on the barrier function of mucus, Int. J. Pharm., 64, 161-169 (1990).
DOI
ScienceOn
|
28 |
A.F. Hofmann and K.J. Mysels, Bile acid solubility and precipitation in vitro and in vivo: the role of conjugation, pH and Ca2+ ions, J. Lipid Res., 33 617-626 (1992).
|
29 |
Y. Shitara and Y. Sugiyama, Pharmacokinetic and pharmacodynamic alterations of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors: drug-drug interactions and interindividual differences in transporter and metabolic enzyme functions, Pharmacol. Ther., 112, 71-105 (2006).
DOI
ScienceOn
|
30 |
L. Forsgren, Studies on the intestinal absorption of labelled fat-soluble vitamins (A, D, E, and K) via the thoracic-duct lymph in the absence of bile in man, Acta Chir. Scand. Suppl., 399, 1-29 (1969).
|
31 |
G.L. Amidon, H. Lennernas, V.P. Shah and J.R. Crison, A theoretical basis for biopharmaceutical drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability, Pharm. Res., 12, 413-420 (1995).
DOI
ScienceOn
|
32 |
M.A. Vandelli, G. Salvioli, A. Mocci, R. Panini, L. Malmusi and F. Forni, 2-Hydroxypropyl-ß-cyclodextrin complexation with ursodeoxycholic acid, Int. J. Pharm., 118, 77-83 (1995).
DOI
ScienceOn
|
33 |
R. Ninomiya, K. Matsuoka and Y. Moroi, Micelle formation of sodium deoxycholate and solubilization into the micelles: comparison with other unconjugated bile salts, Biochem. Biophys. Acta, 1634, (2003).
DOI
ScienceOn
|
34 |
J.R. Crouse III, P. Lukacsko and R. Niecestro, The Lovastatin Extended-Release Study Group, Dose response, safety and efficacy of an extended-release formulation of lovastatin in adults with hypercholesterolemia, Am. J. Cardiol., 89, 226-229 (2002).
DOI
ScienceOn
|
35 |
E. Wang, C.N. Casciano, R.P. Crement and W.W. Johnson, HMG-CoA reductase inhibitors (statins) characterized as direct inhibitors of P-glycoprotein, Pharm. Res., 18, 800-806 (2001).
DOI
ScienceOn
|